Swedbank Ab 10x Genomics, Inc. Transaction History

Swedbank Ab

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 21, 2024	BUY	$36.08 - $54.3 $649,007 - $976,748	17,988 New	17,988 $675 Million
Q4 2023 Dec 09, 2024	SELL	$34.32 - $57.55 $13,728 - $23,020	-400 Reduced 2.47%	15,788 $883,000
Q3 2023 Dec 09, 2024	BUY	$40.86 - $62.98 $69,462 - $107,066	1,700 Added 11.73%	16,188 $667,000
Q2 2023 Dec 09, 2024	BUY	$50.96 - $58.72 $4,484 - $5,167	88 Added 0.61%	14,488 $809,000
Q1 2023 Dec 09, 2024	BUY	$35.33 - $55.79 $9,715 - $15,342	275 Added 1.95%	14,400 $803,000
Q3 2022 Dec 09, 2024	SELL	$28.48 - $52.59 $30,017 - $55,429	-1,054 Reduced 6.94%	14,125 $402,000
Q2 2022 Dec 09, 2024	BUY	$36.95 - $82.41 $560,864 - $1.25 Million	15,179 New	15,179 $686,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.53B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.